Molecular Templates, Inc. (MTEM) financial statements (2021 and earlier)

Company profile

Business Address 9301 AMBERGLEN BLVD
AUSTIN, TX 78729
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments941259859244959
Cash and cash equivalents2585885911108
Short-term investments694010 133950
Receivables080    
Prepaid expense6221   
Other current assets1040   
Other undisclosed current assets 5  148
Total current assets:10114010560245367
Noncurrent Assets
Operating lease, right-of-use asset1110
Property, plant and equipment221872001
Long-term investments and receivables 2     
Long-term investments 2     
Other noncurrent assets5521 01
Other undisclosed noncurrent assets  2727   
Total noncurrent assets:39343530002
TOTAL ASSETS:14017414090245468
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities151665248
Accounts payable2113112
Accrued liabilities131553133
Employee-related liabilities      3
Deferred revenue1417
Debt  02   
Deferred revenue and credits3  15
Other liabilities2300   
Other undisclosed current liabilities6 26 173
Total current liabilities:3836331031126
Noncurrent Liabilities
Long-term debt and lease obligation271531   
Long-term debt, excluding current maturities15331   
Capital lease obligations0    
Operating lease, liability1212
Liabilities, other than long-term debt621122266
Deferred revenue and credits 0062
Deferred revenue519
Other liabilities1111   
Derivative instruments and hedges, liabilities  01224
Other undisclosed noncurrent liabilities10 3    
Total noncurrent liabilities:4335732266
Total liabilities:8171391341392
Stockholders' equity
Stockholders' equity attributable to parent59103101772041(24)
Common stock0000000
Additional paid in capital328267196142373370349
Accumulated other comprehensive income (loss)00  (0)(0)(0)
Accumulated deficit(269)(164)(95)(64)(354)(329)(373)
Total stockholders' equity:59103101772041(24)
TOTAL LIABILITIES AND EQUITY:14017414090245468

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenue, net1 7715
Gross profit: 22133 7715
Operating expenses(120)(93)(44)(21)(24)(50)(46)
Other undisclosed operating income19      
Operating income (loss):(101)(70)(31)(18)(24)27(31)
Nonoperating income 0  0179
Investment income, nonoperating 0    9
Other nonoperating income    017 
Interest and debt expense(1)(0)(0)(5)   
Other undisclosed income from continuing operations before equity method investments, income taxes    000
Income (loss) from continuing operations before equity method investments, income taxes:(102)(70)(31)(23)(24)44(22)
Other undisclosed loss from continuing operations before income taxes(3)      
Income (loss) from continuing operations before income taxes:(105)(70)(31)(23)(24)44(22)
Income tax expense (benefit)(0)     0
Net income (loss):(105)(70)(31)(23)(24)44(22)
Other undisclosed net income attributable to parent 110   
Net income (loss) attributable to parent:(105)(69)(30)(23)(24)44(22)
Preferred stock dividends and other adjustments   (1)   
Net income (loss) available to common stockholders, basic:(105)(69)(30)(24)(24)44(22)
Dilutive securities, effect on basic earnings per share     (4)(9)
Net income (loss) available to common stockholders, diluted:(105)(69)(30)(24)(24)40(31)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):(105)(70)(31)(23)(24)44(22)
Other comprehensive income (loss)(0)0     
Comprehensive income (loss):(105)(70)(31)(23)(24)44(22)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent 11(1)0(0)(0)
Comprehensive income (loss), net of tax, attributable to parent:(105)(69)(30)(24)(24)44(22)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: